Wooree BioLtd Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Wooree BioLtd zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Semiconductor Gewinnwachstum	38.0%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

Oct 23

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Sep 07

Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Aug 30

Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Aug 10

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Jul 19

Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

May 25

These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

May 03

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Apr 26

Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

Feb 28

Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Feb 01

Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 12

Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Dec 21

Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

Nov 29

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da Wooree BioLtd jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

KOSDAQ:A082850 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	1,303,982	15,866	25,739	44,173	N/A
3/31/2024	1,288,391	16,261	44,468	54,973	N/A
12/31/2023	1,263,944	15,581	15,949	26,515	N/A
9/30/2023	1,210,018	12,899	-3,787	7,103	N/A
6/30/2023	1,168,690	10,404	10,472	20,860	N/A
3/31/2023	1,272,911	15,987	13,921	24,851	N/A
12/31/2022	1,355,056	21,822	29,928	43,353	N/A
9/30/2022	1,483,231	31,107	42,632	58,779	N/A
6/30/2022	1,528,819	32,785	51,628	64,832	N/A
3/31/2022	1,527,452	30,711	23,081	38,679	N/A
12/31/2021	1,543,312	33,156	37,443	50,208	N/A
9/30/2021	1,577,021	23,351	20,247	31,361	N/A
6/30/2021	1,668,108	23,949	34,862	48,264	N/A
3/31/2021	1,621,467	23,288	61,417	76,607	N/A
12/31/2020	1,623,383	16,841	51,328	69,427	N/A
9/30/2020	1,600,031	21,438	70,133	87,897	N/A
6/30/2020	1,580,796	17,503	12,244	31,127	N/A
3/31/2020	1,682,915	3,729	54,394	74,655	N/A
12/31/2019	1,672,648	4,532	42,005	65,803	N/A
9/30/2019	1,635,873	-2,060	9,445	35,163	N/A
6/30/2019	1,539,163	-10,321	38,810	66,582	N/A
3/31/2019	1,358,099	-18,184	-15,433	15,941	N/A
12/31/2018	1,279,627	-32,888	-18,441	10,824	N/A
9/30/2018	1,343,043	-46,169	-16,431	18,908	N/A
6/30/2018	1,258,947	-43,525	21,010	63,020	N/A
3/31/2018	1,359,443	-33,208	N/A	22,586	N/A
12/31/2017	1,474,632	-28,041	N/A	27,730	N/A
9/30/2017	1,391,349	-4,458	N/A	22,482	N/A
6/30/2017	1,497,664	-11,950	N/A	-12,865	N/A
3/31/2017	1,489,526	-21,295	N/A	20,483	N/A
12/31/2016	1,533,519	-23,261	N/A	-1,948	N/A
9/30/2016	1,290,944	-57,516	N/A	-1,215	N/A
6/30/2016	1,327,188	-55,845	N/A	16,492	N/A
3/31/2016	1,803,498	-48,526	N/A	-3,492	N/A
12/31/2015	1,764,595	-42,887	N/A	-11,529	N/A
9/30/2015	2,055,453	-19,841	N/A	53,573	N/A
6/30/2015	1,921,805	-18,299	N/A	56,328	N/A
3/31/2015	1,394,152	-23,046	N/A	64,814	N/A
12/31/2014	1,305,507	-29,308	N/A	54,312	N/A
9/30/2014	1,055,754	-29,361	N/A	-10,241	N/A
6/30/2014	1,099,397	-31,564	N/A	-37,988	N/A
3/31/2014	1,055,242	-19,463	N/A	-27,255	N/A
12/31/2013	1,039,767	-10,886	N/A	80,751	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von A082850 über der Sparquote liegt (2.7%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von A082850 schneller wachsen werden als der Markt KR

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von A082850 in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von A082850 schneller wachsen werden als der Markt von KR.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von A082850 schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von A082850 in 3 Jahren voraussichtlich hoch sein wird

Wooree BioLtd Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

New minor risk - Market cap size

Now 24% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

New major risk - Financial data availability

Investor sentiment improves as stock rises 25%

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Investor sentiment deteriorates as stock falls 16%

Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Investor sentiment improves as stock rises 16%

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Investor sentiment improves as stock rises 29%

Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

Full year 2023 earnings released: EPS: ₩331 (vs ₩469 in FY 2022)

New minor risk - Market cap size

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 31%

New major risk - Share price stability

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 25%

Investor sentiment deteriorates as stock falls 17%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Investor sentiment improved over the past week

Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

New 90-day low: ₩4,910

Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Investor sentiment deteriorated over the past week

Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Investor sentiment deteriorated over the past week

Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Investor sentiment deteriorated over the past week

Market bids up stock over the past week

Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

Market bids up stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

New 90-day high: ₩4,600

New 90-day high - ₩3,595

New 90-day high - ₩1,280

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken